We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Oncolytics Biotech® Starts Enrolment in U.S. Phase 2 Pancreatic Cancer Clinical Trial

News   May 27, 2010

 
Oncolytics Biotech® Starts Enrolment in U.S. Phase 2 Pancreatic Cancer Clinical Trial
 
 
 

RELATED ARTICLES

Protein Curbs Obesity Through Our Gut Bacteria

News

Scientists from the UNC School of Medicine discovered that the anti-inflammatory protein NLRP12 normally helps protect mice against obesity and insulin resistance when they are fed a high-fat diet. The researchers also reported that the NLRP12 gene is underactive in people who are obese, making it a potential therapeutic target for treating obesity and diabetes.

READ MORE

Existing Drug Could Treat Porphyria

News

An existing antifungal drug, ciclopirox (CPX), has been shown to improve symptoms associated with congenital erythropoietic porphyria – the rarest type of porphyria.

READ MORE

Obesity & Vitamin D Deficiency May Indicate Greater Breast Cancer Risk

News

New study demonstrates that postmenopausal women have an increased risk of vitamin D deficiency at the time of breast cancer diagnosis, associated with a higher rate of obesity.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE